References
- Roy PK, Venzon DJ, Shojamanesh H, Abou-Saif A, Peghini P, Doppman JL, Gibril F, Jensen RT. Zollinger-Ellison syndrome: clinical presentation in 261 patients. Medicine 79:379-411, 2000 https://doi.org/10.1097/00005792-200011000-00004
- Jensen RT. Use of omeprazole and other proton pump inhibitors in the Zollinger-Ellison syndrome. In: Olbe L, ed. Milestones in drug therapy. 10th ed. p. 205, Basel, Birkhauser Verlag AG, 1999
- Mignon M, Cadiot G, Rigaud D, Ruszniewski PH, Jais P, Lehy T, Lewin MJ. Management of islet cell tumors in patients with multiple endocrine neoplasia type 1. In: Mignon M, Jensen RT, eds. Endocrine tumors of the pancreas: recent advances in research and management. p. 342-359, Basel, Karger, 1995
- Zollinger RM, Ellison EH. Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas. Ann Surg 142:709-723, 1955 https://doi.org/10.1097/00000658-195510000-00015
- Hoffmann KM, Gibril F, Entsuah LK, Serrano J, Jensen RT. Patients with multiple endocrine neoplasia type 1 with gastrinomas have an increased risk of severe esophageal disease including stricture and the premalignant condition, Barrett's esophagus. J Clin Endocrinol Metab 91:204-212, 2006 https://doi.org/10.1210/jc.2005-1349
- Gibril F, Schumann M, Pace A, Jensen RT. Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature. Medicine 83:43-83, 2004 https://doi.org/10.1097/01.md.0000112297.72510.32
- Jensen RT. Gastrointestinal endocrine tumours: gastrinoma. Baillieres Clin Gastroenterol 10:603-643, 1996 https://doi.org/10.1016/S0950-3528(96)90016-0
- Stabile BE, Morrow DJ, Passaro E Jr. The gastrinoma triangle: operative implication. Am J Surg 147:25-31, 1984 https://doi.org/10.1016/0002-9610(84)90029-1
- Ellison EH, Wilson SD. The Zollinger-Ellison syndrome: reappraisal and evaluation of 260 registered cases. Ann Surg 160:512-530, 1964 https://doi.org/10.1097/00000658-196409000-00013
- Creutzfeldt W, Arnold R, Creutzfeldt C, Track NS. Pathomorphologic, biochemical and diagnostic aspects of gastrinomas (zollinger-Ellison syndrome). Hum Pathol 6:47-76, 1975 https://doi.org/10.1016/S0046-8177(75)80109-2
- Norton JA, Fraker DL, Alexander HR, Venzon DJ, Doppman JL, Serrano J, Goebel SU, Peghini PL, Roy PK, Gibril F, Jensen RT. Surgery to cure the Zollinger-Ellison syndrome. N Engl J Med 341:635-644, 1999 https://doi.org/10.1056/NEJM199908263410902
- Orloff SL, Debas HT. Advances in management of patients with Zollinger-Ellison syndrome. Surg Clin North Am 75:511-524, 1995
- Gibril F, Reynolds JC, Doppman JL, Chen CC, Venzon DJ, Termanini B, Weber HC, Stewart CA, Jensen RT. Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas: a prospective study. Ann Intern Med 125:26-34, 1996
- van Eijck CH, Lamberts SW, Lemaire LC, Jeekel H, Bosman FT, Reubi JC, Bruining HA, Krenning EP. The use of somatostatin receptor scintigraphy in the differential diagnosis of pancreatic duct cancers and islet cell tumors. Ann Surg 224:119-124, 1996 https://doi.org/10.1097/00000658-199608000-00002
- Anderson MA, Carpenter S, Thompson NW, Nostrant TT, Elta GH, Scheiman JM. Endoscopic ultrasound is highly accurate and directs management in patients with neuroendocrine tumors of the pancreas. Am J Gastroenterol 95:2271-2277, 2000 https://doi.org/10.1111/j.1572-0241.2000.02480.x
- Akerstrom G, Hessman O, Skogseid B. Timing and extent of surgery in symptomatic and asymptomatic neuroendocrine tumors of the pancreas in MEN 1. Langenbecks Arch Surg 386:558-569, 2002 https://doi.org/10.1007/s00423-001-0274-6